BORA - UiB

Bergen Open Research Archive

Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel

Bergen Open Research Archive

Files in this item

 

This item appears in the following Collection(s)

Copyright 2011 Chrisanthar et al. Except where otherwise noted, this item's license is described as Copyright 2011 Chrisanthar et al.

Search BORA


Browse

My Account